Investors
AdBio Partners

AdBio Partners is a venture capital fund based in France that invests in early-stage biotech and health tech companies. Specializing in seed and series A investments, the fund supports groundbreaking medical and clinical innovations. Established in 2015 and AMF regulated since 2016, AdBio Partners collaborates with top research institutions to bring new discoveries to market. They have funded companies such as Astraveus, Orikine Bio, and AgomAb Therapeutics. Their mission is to improve patient care and advance medical innovations, thereby strengthening France's biotechnology ecosystem.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Recent Investments